Skip to main content
. 2017 Nov 21;91(1089):20170344. doi: 10.1259/bjr.20170344

Figure 4.

Figure 4.

 Emerging application of PDFF and R2* measurement in spondyloarthritis. Areas of active inflammation (a, c) demonstrate a reduction in fat content, but no change in R2*. Areas of chronic inflammation (fat metaplasia) (b, d) demonstrate an increase in fat content, and a reduction in R2* which may indicate local osteoporosis.